Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Liraglutide clinical trials
12 selected ClinicalTrials.gov records carrying the official matched intervention Liraglutide (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
12 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 58 selected PubMed records and 13 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT04775082
ClinicalTrials.gov posted a newer version of NCT04775082, with a registry update date of 2026-11-16. This version reports that observation; the earlier retained observation remains available as version 1.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 16, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06976619
PeptideScanner retained ClinicalTrials.gov record NCT06976619 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-19, and PeptideScanner's reviewed identity mapping was liraglutide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- October 19, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT04575844
PeptideScanner retained ClinicalTrials.gov record NCT04575844 at 2026-07-30T16:19:36.923Z. Its registry update date was 2026-05-06, and PeptideScanner's reviewed identity mapping was liraglutide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- May 6, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Liraglutide · 2026-11-16
ClinicalTrials.gov record NCT04775082
Active, not recruiting at the retained observation.
Open attributed record →Liraglutide · 2026-10-19
ClinicalTrials.gov record NCT06976619
Recruiting at the retained observation.
Open attributed record →Liraglutide · 2026-08-12
ClinicalTrials.gov record NCT03883412
Recruiting at the retained observation.
Open attributed record →Liraglutide · 2026-08-06
ClinicalTrials.gov record NCT05313529
Completed at the retained observation.
Open attributed record →Liraglutide · 2026-07-27
ClinicalTrials.gov record NCT07225829
Active, not recruiting at the retained observation.
Open attributed record →Liraglutide · 2026-05-06
ClinicalTrials.gov record NCT04575844
Recruiting at the retained observation.
Open attributed record →Liraglutide · 2023-07-18
ClinicalTrials.gov record NCT03374956
Completed at the retained observation.
Open attributed record →Liraglutide · 2015-03-25
ClinicalTrials.gov record NCT01755572
Completed at the retained observation.
Open attributed record →Liraglutide · 2014-09-12
ClinicalTrials.gov record NCT01270789
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-10-09
ClinicalTrials.gov record NCT01394341
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-04-19
ClinicalTrials.gov record NCT01469351
Completed at the retained observation.
Open attributed record →Liraglutide · 2012-09-27
ClinicalTrials.gov record NCT01695109
Completed at the retained observation.
Open attributed record →